This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Elsevier Launches Genomics Data App In Collaboration With Illumina

Stocks in this article: ENL RUK

CAMBRIDGE, Massachusetts, May 20, 2013 /PRNewswire/ --

Genomics Data App now available in BaseSpace Apps

Elsevier, a world-leading provider of scientific, medical and technical products and services, announces the launch of the Genomics Data app in collaboration with Illumina, a sequencing and array-based solutions provider for genetics research.

The app allows researchers to share large data sets in Illumina's BaseSpace cloud, where they can easily be reviewed and included in Elsevier's open access journal, Genomics Data . The BaseSpace app serves as a gateway, opening data stored in the cloud to the publishing environment for expert peer review and wide dissemination in the form of a professional publication.

"In genomic studies we often generate large data sets of tremendous value. Without a means to publish these data sets and get credit for them, they easily get lost," said John Quackenbush, Co-Editor-in-Chief of Genomics Data. "By working together with Illumina to develop a reviewing pipeline from BaseSpace to Genomics Data, we've created a simple way for researchers to make genomic data accessible to publication in a journal."

Through BaseSpace, authors and reviewers will also have additional access to analytical tools, further enhancing Genomics Data ' s peer review process. This enhanced review option can give an article attached to the data set added credibility because reviewers are in the position to reproduce the analysis that the authors did.

"Uploading genomic data to BaseSpace has reached critical mass. The innovative development of the Genomics Data App demonstrates how Elsevier is able to create new and unique opportunities for researcher collaboration," said Alex Dickinson, Senior Vice President, Cloud Genomics at Illumina.

To view the app, please register for free on:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,446.19 +58.98 0.34%
S&P 500 2,032.35 +2.80 0.14%
NASDAQ 4,708.2790 +26.7820 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs